gracecast-086_lung-cancer_q&a with drs. solomon and camidge on alk inhibition for advanced nsclc
Published 12 years ago • 318 plays • Length 12:46Download video MP4
Download video MP3
Similar videos
-
17:30
gracecast-084_lung-cancer_alk inhibition: science and early clinical experience by dr. ben solomon
-
26:56
gracecast-085_lung-cancer_alk inhibition: who to screen and options for alk-positive patients
-
37:41
gracecast-044_lung-cancer_camidge on alk inhibitors
-
5:42
gracecast - lcvl- what are the options after a patient with an alk-positive advanced nsclc develops
-
10:37
gracecast-141_lung_highlights in lung cancer, 2012: alk inhibitors for patients with alk or ros1
-
5:11
gracecast-114_lung-cancer_asco 2012 lc highlights: dr. neal on mek inhibitor selumetinib in nsclc
-
13:00
stage 3a node-positive lung adenocarcinoma with alk rearrangement - case based panel discussions
-
3:44
alk inhibitors for acquired resistance: zykadia and alectinib
-
3:06
2020 ttf alk session qa panel progression on 2nd-gen alk inhibitor if biopsy shows no alk mutation
-
2:00
ceritinib and other second generation alk inhibitors for acquired resistance in alk-positive nsclc
-
6:49
can we improve on xalkori? new agents for patients with an alk-1 rearrangement
-
13:40
gracecast-104_lung-cancer_immunotherapy for lung cancer: q and a session
-
4:58
how do the new alk inhibitor drugs compare to xalkori (crizotinib) for alk lung cancer patients?
-
7:41
gracecast - lcvl - h. jack west md - can alk inhibitors treat and prevent brain metastases
-
15:20
gracecast-057_lung-cancer_expert round table - optimal nsclc treatment for elderly / frail
-
4:14
can or will specific molecular characteristics help determine which alk inhibitor to choose?
-
1:47
alk rearrangements: what are they, and who has them?
-
9:26
gracecast - lcvl - which patients with advanced nsclc are good candidates for first line immunothera
-
2:15
new alk inhibitor drugs vs xalkori (crizotinib) for alk lung cancer patients